MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 16.03.2026
Rafael Holdings P/CF 2011-2026 | RFL
P/CF Jährlich Rafael Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.08 | -4.08 | -3.68 | -1.37 | -3.18 | -50.9 | -75.9 | -46.4 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.37 | -75.9 | -23.5 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-1.79 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-0.848 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
-11.8 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | France |
 |
AstraZeneca PLC
AZN
|
9.7 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-30.2 | - | 0.74 % | $ 768 M |  Israel |
 |
Galera Therapeutics
GRTX
|
-0.63 | - | -32.59 % | $ 7.61 M | USA |
 |
Esperion Therapeutics
ESPR
|
-42.9 | $ 3.13 | - | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
53.1 | $ 34.45 | 4.74 % | $ 927 M | USA |
 |
Midatech Pharma plc
MTP
|
-117 | - | -18.52 % | $ 27.3 M | Britain |
|
Forte Biosciences
FBRX
|
-6.59 | $ 20.31 | 1.2 % | $ 263 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | USA |
 |
Grifols, S.A.
GRFS
|
5.01 | $ 8.19 | 4.46 % | $ 5.57 B |  Spain |
 |
Celyad Oncology SA
CYAD
|
-0.379 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
-2.92 | $ 6.82 | 1.94 % | $ 187 M | Israel |
 |
Generation Bio Co.
GBIO
|
-3.39 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-0.195 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
BioNTech SE
BNTX
|
48.3 | $ 90.36 | 2.93 % | $ 21.8 B | Germany |
 |
Autolus Therapeutics plc
AUTL
|
-1.14 | $ 1.62 | -0.61 % | $ 431 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.0137 | - | -4.36 % | $ 27 M | USA |
 |
Compugen Ltd.
CGEN
|
6.2 | $ 2.71 | -0.92 % | $ 253 M | Israel |
 |
Anika Therapeutics
ANIK
|
19.1 | $ 15.14 | 2.16 % | $ 217 M | USA |
 |
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
-1.01 | - | 5.93 % | $ 314 M | Canada |
 |
Incyte Corporation
INCY
|
13.8 | $ 97.08 | 1.55 % | $ 19 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.205 | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.39 | 4.17 % | $ 5.58 M | Israel |
 |
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | USA |
 |
Coherus BioSciences
CHRS
|
-1.63 | $ 1.51 | 2.03 % | $ 177 M | USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-612 | $ 20.47 | 4.97 % | $ 2.6 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | USA |